Alterity Therapeutics Limited logo

ATHEAlterity Therapeutics Limited

ATHE Stock Price, Valuation & Chart | Alterity Therapeutics Limited

Compare

ATHE Historical price chart

ATHE Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization76.57M
PE Ratio-5.78
EPS-0.78
Trading Volume7.36K
Today's High/Low4.61/4.5
Dividend Yield0.00
52 Week High/Low5.89/2.66
Shares Outstanding16.94M
ATHE Financial Statement
ATHE Analyst ratings
ATHE Analysis & performance metrics

ATHE Company profile

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other…

ATHE Management team

Management
Abby Macnish Niven B.Com., B.Sc., C.F.A.CFO
Chief Financial Officer & Company Secretary
Steven D. Targum M.D.
Chief Medical Advisor
Geoffrey Paul Kempler B.Sc.
Co-Founder & Non-Executive Chairman
David A. Stamler M.D.CEO
Chief Executive Officer
Robert Cherny
Head of Research
Rudolph Emile Tanzi Ph.D.
Chief Scientific Advisor and Member of Research & Development Advisory Board
Total 6 executives

ATHE Frequently asked questions

What is Alterity Therapeutics Limited (ATHE) Stock Price?

Current stock price of Alterity Therapeutics Limited (ATHE) stock is $4.520. The stock price is -0.66% lower in the session. The intraday range can be seen from this page. Volume of Alterity Therapeutics Limited (ATHE) stock is 7.36K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Alterity Therapeutics Limited (ATHE) stock price going up or down today?

The stock price of Alterity Therapeutics Limited (ATHE) can change with earnings, company news, and overall market sentiment. Alterity Therapeutics Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Alterity Therapeutics Limited stock expensive at its current price?

Whether Alterity Therapeutics Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ATHE on this page is -5.78. EPS on this page is -0.78. Compare those figures with peers and growth expectations before deciding if the current Alterity Therapeutics Limited price is justified.

How has the stock price of Alterity Therapeutics Limited (ATHE) performed historically?

Historical performance for Alterity Therapeutics Limited (ATHE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ATHE reacted to past earnings and market events.

Should I buy Alterity Therapeutics Limited (ATHE) stock, at this price?

Buying Alterity Therapeutics Limited (ATHE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.